Iterum Therapeutics plc — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/37135370-cbd2-4fcc-89de-1d026f86d07a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-18.7M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-015857 |
| FY 2023 | $-47.5M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-037615 |
| FY 2022 | $-30.4M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-008300 |
| FY 2021 | $-24.5M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-011897 |
| FY 2020 | $-32.1M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012694 |
| FY 2019 | $-102.0M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010242 |
| FY 2018 | $-76.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-009089 |
| FY 2017 | $-29.5M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-009089 |
| FY 2016 | $-13.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-009089 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).